{
  "items": "9",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "Perceptive Capital Solutions Corp. (NASDAQ:PCSC) Short Interest Update",
      "url": "https://www.marketbeat.com/instant-alerts/perceptive-capital-solutions-corp-nasdaqpcsc-short-interest-update-2025-12-24/",
      "time_published": "20251225T000950",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Perceptive Capital Solutions Corp. (NASDAQ:PCSC) experienced a significant 13,815.1% surge in short interest to 281,642 shares as of December 15th, although its days-to-cover ratio remains low at 0.6 days. Institutional investors, including Radcliffe Capital Management and Sculptor Capital LP, have adjusted their positions. Wall Street sentiment remains negative, with a consensus \"Sell\" rating, and the stock is currently trading around $13.59.",
      "banner_image": "https://www.marketbeat.com/logos/perceptive-capital-solutions-corp-logo-1200x675.png?v=20241030165920",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.802886"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.722890"
        }
      ],
      "overall_sentiment_score": -0.403674,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.447838",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Perceptive Capital Solutions (NASDAQ:PCSC) Shares Up 2.2% - Here's Why",
      "url": "https://www.marketbeat.com/instant-alerts/perceptive-capital-solutions-nasdaqpcsc-shares-up-22-heres-why-2025-12-19/",
      "time_published": "20251219T080939",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Perceptive Capital Solutions (NASDAQ:PCSC) saw its shares rise 2.2% on Thursday, trading as high as $12.75 with a significant increase in trading volume. Despite this uptick, analyst sentiment remains negative, with Weiss Ratings reiterating a \"Sell\" rating for the company. Institutional investors, including Sculptor Capital LP, have recently adjusted their positions in the blank check company, which has a market cap of $109.24 million.",
      "banner_image": "https://www.marketbeat.com/logos/perceptive-capital-solutions-corp-logo-1200x675.png?v=20241030165920",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.942917"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.903463"
        },
        {
          "topic": "finance",
          "relevance_score": "0.809655"
        }
      ],
      "overall_sentiment_score": -0.203408,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.211227",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "United States - Goodwin Advised Freenome On $330 Million DeSPAC With Perceptive Capital Solutions At A Target $1.1 Billion Valuation",
      "url": "https://www.mondaq.com/pressrelease/183236/goodwin-advised-freenome-on-%24330-million-despac-with-perceptive-capital-solutions-at-a-target-%2411-billion-valuation",
      "time_published": "20251211T220954",
      "authors": [
        "NULL"
      ],
      "summary": "Goodwin Procter LLP advised Freenome on a definitive business combination agreement with Perceptive Capital Solutions Corp (PCSC), a SPAC. This DeSPAC transaction is valued at approximately $330 million, expecting to result in a post-transaction equity value of $1.1 billion. Freenome, an early cancer detection company using AI and machine learning with a multiomics platform, will be renamed Freenome, Inc. and listed on Nasdaq under \"FRNM.\"",
      "banner_image": "NULL",
      "source": "Mondaq",
      "category_within_source": "General",
      "source_domain": "Mondaq",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.929971"
        },
        {
          "topic": "finance",
          "relevance_score": "0.841230"
        }
      ],
      "overall_sentiment_score": 0.357114,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.427055",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "AMGN",
          "relevance_score": "0.623904",
          "ticker_sentiment_score": "0.256831",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC Merger",
      "url": "https://dealbreaker.com/2025/12/liquid-biopsy-firm-freenome-finds-a-way-to-the-public-markets-via-330m-spac-merger-",
      "time_published": "20251209T130950",
      "authors": [
        "Frank Vinluan"
      ],
      "summary": "Freenome, a developer of liquid biopsy tests for early cancer detection, is going public through a SPAC merger with Perceptive Capital Solutions Corp, bringing in $330 million to advance its pipeline. The company's colorectal cancer test, SimpleScreen, is currently under FDA review, with commercialization anticipated in 2026. This deal positions Freenome to compete in the growing multi-billion dollar early cancer detection market.",
      "banner_image": "https://dealbreaker.com/.image/ar_16:9%2Cc_fill%2Ccs_srgb%2Cfl_progressive%2Cg_faces:center%2Cq_auto:good%2Cw_768/MjE5NzY2NjE0Nzg5MjAzMDE0/test-tube.jpg",
      "source": "Dealbreaker",
      "category_within_source": "General",
      "source_domain": "Dealbreaker",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.941823"
        },
        {
          "topic": "ipo",
          "relevance_score": "0.911625"
        },
        {
          "topic": "finance",
          "relevance_score": "0.714550"
        }
      ],
      "overall_sentiment_score": 0.549115,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.523957",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Freenome to go public with PCSC (Nasdaq: PCSC) in $1.1B SPAC, $240M PIPE deal",
      "url": "https://www.stocktitan.net/news/PCSC/freenome-and-perceptive-capital-solutions-corp-announce-business-24r7bjpvsr9d.html",
      "time_published": "20251205T140946",
      "authors": [
        "NULL"
      ],
      "summary": "Freenome is set to become a publicly listed company, trading as FRNM on Nasdaq, through a definitive business combination agreement with Perceptive Capital Solutions Corp (PCSC). This $1.1 billion SPAC deal includes a $240 million PIPE investment led by Perceptive Advisors and RA Capital, alongside approximately $90 million from PCSC's trust funds, aiming to provide about $330 million in proceeds. The funds will accelerate Freenome's AI/ML multiomics platform, support commercial scaling for 2026 test launches, and advance its pipeline, including partnerships with Exact Sciences and Roche.",
      "banner_image": "https://mma.prnewswire.com/media/1934326/Freenome_Logo.jpg",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "ipo",
          "relevance_score": "1.000000"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.842181"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.920488"
        }
      ],
      "overall_sentiment_score": 0.251195,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.424719",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "EXC",
          "relevance_score": "0.628866",
          "ticker_sentiment_score": "0.109718",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Freenome Holdings, Inc. entered into a definitive business combination agreement to acquire Perceptive Capital Solutions Corp from Perceptive Capital Solutions Holdings and others in a reverse merger transaction for $330 million.",
      "url": "https://www.marketscreener.com/news/freenome-holdings-inc-entered-into-a-definitive-business-combination-agreement-to-acquire-percepti-ce7d51d2db8eff24",
      "time_published": "20251205T140928",
      "authors": [],
      "summary": "Freenome Holdings, Inc. has entered into a definitive business combination agreement to acquire Perceptive Capital Solutions Corp in a reverse merger transaction valued at $330 million. Upon closing in the first half of 2026, Perceptive Capital Solutions Corp will be renamed Freenome, Inc. and its common stock will be listed on Nasdaq under the ticker symbol \"FRNM.\" This transaction has been unanimously approved by the boards and special committees of both companies, and it includes subscription agreements with various institutional and accredited investors.",
      "banner_image": null,
      "source": "www.marketscreener.com",
      "category_within_source": "General",
      "source_domain": "www.marketscreener.com",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.819729"
        },
        {
          "topic": "ipo",
          "relevance_score": "0.746636"
        },
        {
          "topic": "finance",
          "relevance_score": "0.618426"
        }
      ],
      "overall_sentiment_score": 0.406661,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.442537",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Perceptive Capital Solutions announces merger with Freenome",
      "url": "https://www.msn.com/en-us/money/savingandinvesting/perceptive-capital-solutions-announces-merger-with-freenome/ar-AA1RNhW0",
      "time_published": "20251205T140928",
      "authors": [],
      "summary": "This article announces that Perceptive Capital Solutions has merged with Freenome. The merger brings together a capital solutions provider with an innovative health technology company. Further details regarding the implications of this merger for both companies and their stakeholders would be in the full article.",
      "banner_image": null,
      "source": "MSN",
      "category_within_source": "General",
      "source_domain": "MSN",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.924656"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.725741"
        }
      ],
      "overall_sentiment_score": 0.51013,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.531907",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Freenome, Perceptive Capital Solutions announce business combination agreement",
      "url": "https://www.tipranks.com/news/the-fly/freenome-perceptive-capital-solutions-announce-business-combination-agreement-thefly",
      "time_published": "20251205T140928",
      "authors": [],
      "summary": "Freenome Holdings and Perceptive Capital Solutions (PCSC) have announced a definitive business combination agreement. Upon closing, PCSC will redomicile as a Delaware corporation, be renamed Freenome, and list on Nasdaq under the ticker symbol \u201cFRNM.\u201d The transaction, expected to close in the first half of 2026, will provide Freenome with approximately $330M, combining PCSC's trust account funds with a $240M common equity PIPE.",
      "banner_image": null,
      "source": "TipRanks",
      "category_within_source": "General",
      "source_domain": "TipRanks",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.822698"
        },
        {
          "topic": "ipo",
          "relevance_score": "0.703021"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.702150"
        }
      ],
      "overall_sentiment_score": 0.415682,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.429893",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Perceptive Capital Solutions Corp Prices of $75 Million IPO",
      "url": "https://www.citybiz.co/article/566327/perceptive-capital-solutions-corp-prices-of-75-million-ipo/",
      "time_published": "20240612T000000",
      "authors": [
        "NULL"
      ],
      "summary": "Perceptive Capital Solutions Corp has priced its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share, totaling $75 million. The shares will trade on The Nasdaq Global Market under the ticker symbol \"PCSC\" starting June 12, 2024. The special purpose acquisition company intends to target the healthcare industry for its initial business combination.",
      "banner_image": "NULL",
      "source": "citybiz",
      "category_within_source": "General",
      "source_domain": "citybiz",
      "topics": [
        {
          "topic": "ipo",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.939628"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.839409"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.720469"
        }
      ],
      "overall_sentiment_score": 0.424736,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "PCSC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.402276",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    }
  ]
}